STOCK TITAN

Artivion to Present at the Deutsche Bank 30th Annual Leveraged Finance Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Artivion, Inc. (NYSE: AORT), a prominent company in cardiac and vascular surgery focused on aortic disease, announced it will present at the Deutsche Bank 30th Annual Leveraged Finance Conference on September 21, 2022, at 9:20 a.m. MST. The presentation will be available via a live webcast on the company's website, with an archived version accessible for 90 days. Artivion specializes in developing solutions for aortic diseases, marketing products in over 100 countries. For further details, visit www.artivion.com.

Positive
  • None.
Negative
  • None.

ATLANTA, Sept. 14, 2022 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will present at the upcoming Deutsche Bank 30th Annual Leveraged Finance Conference on Wednesday, September 21, 2022. The Company's presentation is scheduled to begin at 9:20 a.m. MST.

A live webcast of the presentation will be accessible through Artivion's website, www.artivion.com, on the Investors page. An archived copy of the webcast will be available for 90 days on the same website. 

About Artivion, Inc.

Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com.

Contacts:




Artivion

Gilmartin Group LLC

D. Ashley Lee

Brian Johnston / Lynn Lewis

Executive Vice President &

Phone: 332-895-3222

Chief Financial Officer

investors@artivion.com

Phone: 770-419-3355


 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-to-present-at-the-deutsche-bank-30th-annual-leveraged-finance-conference-301624044.html

SOURCE Artivion, Inc.

FAQ

When is Artivion's presentation at the Deutsche Bank conference?

Artivion will present on September 21, 2022, at 9:20 a.m. MST.

How can I watch Artivion's presentation live?

The presentation will be streamed live on Artivion's website, specifically on the Investors page.

Will the Artivion conference presentation be available later?

Yes, an archived copy of the presentation will be accessible for 90 days on Artivion's website.

What is Artivion's focus in the medical field?

Artivion specializes in cardiac and vascular surgery, particularly in treating aortic diseases.

What products does Artivion offer?

Artivion offers aortic stent grafts, surgical sealants, On-X mechanical heart valves, and human tissues for cardiac and vascular applications.

Artivion, Inc.

NYSE:AORT

AORT Rankings

AORT Latest News

AORT Stock Data

1.17B
36.71M
5.51%
87.55%
7.67%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
KENNESAW